Exploring 3D-QSAR for ketolide derivatives as antibacterial agents using CoMFA and CoMSIA

Letters in Drug Design and Discovery

Volumn 7, Issue 3, 2010, Pages 149-159

  Song, Qiu Ling ^a   Sun, Ping Hua ^a   Chen, Wei Min ^a  

^a JINAN UNIVERSITY   (China)

Author keywords

3D QSAR; Antibacterial activity; CoMFA; CoMSIA; Ketolide

Indexed keywords

ANTIINFECTIVE AGENT; KETOLIDE;

ANTIBACTERIAL ACTIVITY; ARTICLE; COMPARATIVE MOLECULAR FIELD ANALYSIS; COMPARATIVE MOLECULAR SIMILARITY INDICES ANALYSIS; CORRELATION COEFFICIENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; STREPTOCOCCUS PNEUMONIAE;

EID: 77949726540     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010790596641     Document Type: Article

References (27)

1. Kaneko, T.; Romero, K.; Li, B.; Buzon, R. Novel tether in ketolide antibiotics. Bioorg. Med. Chem. Lett., 2007, 17, 5049-5053.
2. Denis, A.; Agouridas, C.; Auger, J.; Benedetti, Y.; Bonnefoy, A.; Bretin, F.; Chantot, J.; Dussarat, A.; Fromentin, C; DAmbrieres, S.; Lachaud, S.; Laurin, P.; Martret, O.; Loyau, V.; Tessot, N.; Pejac, J.; Perron, S. Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens. Bioorg. Med. Chem. Lett., 1999, 9, 3075-3080.
3. Ma, Z.; Clark, R.F.; Brazzale, A.; Wang, S.; Rupp, M.J.; Li, L.; Griesgraber, G.; Zhang, S.; Yong, H.; Phan, L.T.; Nemoto, P.A.; Chu, D.T.W.; Plattner, J.J.; Zhang, X.; Zhong, P.; Cao, Z.; Nilius, A.M.; Shortridge, V.D.; Flamm, R.; Mitten, M.; Meulbroek, J.; Ewing, P.; Alder, J.; Sun, Y. Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. J. Med. Chem., 2001, 44, 4137-4156.
4. Wang, G.Q.; Niu, D.Q.; Qiu, Y.L.; Phan, L.T.; Chen, Z.G. ; Polemeropoulos, A.; Sun. Y. Synthesis of novel 6,11-O-bridged bicyclic ketolides via a palladium-catalyzed bis-allylation. Org. Lett. ,2004, 24, 4455-4458.
5. Xu, X.D.; Henninger, T.; Abbanat, D.; Bush, K.; Foleno, B.; Hilliard, J.; Macielag, M. Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes. Bioorg. Med. Chem. Lett., 2005, 15, 883-887.
6. Romero, A.; Liang, C.H.; Chiu, Y.H.; Yao, S.L.; Duffield, J.; Sucheck, S.J.; Marby, K.; Rabuka, D.; Leung, P.Y.; Shue, Y.K.; Ichikawa, Y.; Hwang, C.K. An efficient entry to new sugar modified ketolide antibiotics. Tetrahedron Lett., 2005, 46,1483-1487.
7. Liang, C.H.; Yao, S.; Chiu, Y.H.; Leung, P.Y.; Robert, N.; Seddon, J.; Sears, P.; Hwang, C.K.; Ichikawa, Y.; Romero, A. Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibiotics. Bioorg. Med. Chem. Lett., 2005, 15, 1307-1310.
8. Zhu, B.; Maden, A.; Macielag, M.J. Novel erythromycin A derivatives: synthesis of 11, 12-benzoxazine ketolides. Tetrahedron Lett., 2005, 46, 1783-1785.
9. Nomura, T.; Iwaki, T.; Yasukata, T.; Nishi, K. Narukawa, Y.; Uotani, K. Hori, T. Miwa, H. A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether synthesis and structure-activity relationships. Bioorg. Med. Chem., 2005, 24, 6615-6628.
10. Nomura, T.; Iwaki, T.; Narukawa, Y.; Uotani, K.; Hori, T.; Miwa, H. A new type of ketolide bearing an N-aryl-alkyl acetamide moiety at the C-9 iminoether: Synthesis and structure-activity relationships (2). Bioorg. Med. Chem., 2006, 14, 3697-3711.
11. Grant, E.B.; Guiadeen, D.; Abbanat, D.; Foleno, B.D.; Bush, K.; Macielag, M.J. Synthesis and antibacterial activity of 6-O-heteroaryl-carbamoyl-11,12- lactoketolides. Bioorg. Med. Chem. Lett., 2006, 16, 1929-1933.
12. Burger, M.T.; Lin, X.D.; Chu, D.T.; Hiebert, C.; Rico, A.C.; Seid, M.; Carroll, G.L.; Barker, L.; Huh, K.; Langhorne, M.; Shawar, R.; Kidney, J.; Young, K.; Anderson, S.; Desai, M.C; Plattner, J.J. Synthesis and antibacterial activity of novel C12 vinyl ketolides. J. Med. Chem., 2006, 49, 1730-1743.
13. Burger, M.T.; Hiebert, C.; Seid, M.; Chu, D.T.; Barker, L.; Langhorne, M.; Shawar, R.; Kidney, J.; Desai, M.C.; Plattner, J.J. Synthesis and antibacterial activity of novel C-12 ethyl ketolides. Bioorg. Med. Chem., 2006, 14, 5592-5604.
14. Lin, X.D.; Rico, A.C.; Chu, D.T.; Carroll, ; G.L.; Barker, L.; Shawar, R.; Desai, M.C.; Plattner, J.J. Synthesis and antibacterial activity of C-12 des-methyl ketolides. Bioorg. Med. Chem. Lett., 2006, 16, 4692-4696.
15. Tennakoon, M.A.; Henninger, T.C.; Abbanat, D.; Foleno, B.D.; Hilliard, J.J.; Bush, K.; Macielag, M.J. Synthesis and antibacterial activity of C6-carbazate ketolides. Bioorg. Med. Chem. Lett., 2006, 16, 6231-6235.
16. Zhu, B.; Marinelli, B.A.; Abbanat, D.; Foleno, B.D.; Bush, K.; Macielag, M.J. Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives. Bioorg. Med. Chem. Lett., 2007, 17, 3900-3904.
17. Kaneko, T.; McMillen, W.; Lynch, M.K. Synthesis and antibacterial activity of C11, C12-cyclic urea analogues of ketolides. Bioorg. Med. Chem. Lett., 2007, 17, 5013-5018.
18. Andreotti, D.; Bientinesi, I.; Biondi, S.; Donati, D.; Erbetti, I; Lociuro, S.; Marchioro, C.; Pozzan, A.; Ratti, E.; Terreni, S. A novel ketolide class: Synthesis and antibacterial activity of a lead compound. Bioorg. Med. Chem. Lett., 2007, 17, 5265-5269.
19. Cramer, R.D.; Patterson, D.E.; Bunce, J.D. J.D. J. Am. Chem. Soc., 1988, 110, 5959-5967.
20. Yang, Z.Q.; Sun, P.H.; Chen, W.M. 3D-QSAR analysis on pyrrolopyridine analogs as mitogen- activated protein kinase-activated protein kinase 2 (MK-2) inhibitors. Lett. Drug Des. Discov., 2007, 4, 557-561.
21. Sun, P.H.; Yang, Z.Q.; Chen, W.M. QSAR analysis on N-Phenylacetanoyl-L- homoserine lactones as inhibitors of bacterial quorum sensing via CoMFA approach. Lett. Drug Des. Discov., 2008, 5, 449-453.
22. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem., 1994, 37, 4130-4146.
23. Basu, A.; Jasu, K.; Jayaprakash, V.; Mishra, N.; Ojha, P.; Bhattacharya, S. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives. Eur. J. Med. Chem., 2009, 44, 2400-2407.
24. Sybyl 7.0, Tripos Inc.; St. Louis, US, 2004.
25. Clark, M.; Cramer, R.D.; Van Opdenbosch, N. Validation of the general purpose tripos 5.2 force field. J. Comput. Chem., 1989,10, 982-1012.
26. Liu, H.Y.; Liu, S.S.; Qin, L.T.; Mo, L.Y. CoMFA and CoMSIA analysis of 2,4-thiazolidinediones derivatives as aldose reductase inhibitors. J. Mol. Model., 2009, 15, 837-845.
27. Zhu, Y.Q.; Lei, M.; Lu, A.J.; Zhao, X.; Yin, X.J.; Gao, Q.Z. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods. Eur. J. Med. Chem., 2009, 44, 1486-1499.